-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi partners with Cheplapharm, takes 26.4% stake as it hands over mature drugs portfolio

PUBT·09/17/2026 10:10:20
Listen to the news
Sanofi partners with Cheplapharm, takes 26.4% stake as it hands over mature drugs portfolio
  • Sanofi plans a strategic partnership with Cheplapharm, transferring 20 mature medicines and three manufacturing sites.
  • Sanofi will receive a 26.4% equity stake in Cheplapharm, extending a collaboration that began in 2014.
  • Commercial transfer is slated to start in Q1 2027; the transaction is expected to complete by Q3 2027.
  • Three sites slated for transfer: Csanyikvölgy, Hungary; Jurong, Singapore; Ploërmel, France.
  • Sanofi expects no change to its 2026 financial guidance; divested products include Lovenox/Clexane.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-393653), on September 17, 2026, and is solely responsible for the information contained therein.